Predicting the added benefit of adjuvant chemotherapy
- Author
- The Lancet
- Published
- Wed 19 Feb 2020
- Episode Link
- None
Prof Anant Madabhushi and Dr Samuel talk about the utility of a radiomic risk score applied to CT scans of patients with early stage non-small cell lung carcinoma.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
